Safety of Pediatric HIV Elimination: The Growing Population of HIV- and Antiretroviral-Exposed but Uninfected Infants

PLoS Medicine

Volumn 11, Issue 4, 2014, Pages

  Mofenson, Lynne M ^a   Watts, D Heather ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b U S DEPARTMENT OF STATE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; TENOFOVIR; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ARTICLE; BIRTH DEFECT; CLINICAL EDUCATION; DISEASE ELIMINATION; DISEASE SURVEILLANCE; DRUG EXPOSURE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOTHER TO CHILD HIV TRANSMISSION; PATIENT CODING; PREGNANT WOMAN; TERATOGENESIS; VIRUS TRANSMISSION; CHEMICALLY INDUCED; CONGENITAL ABNORMALITIES; CONGENITAL HEART MALFORMATION; EPIDEMIOLOGY; FEMALE; HIV INFECTIONS; PREGNANCY; PRENATAL EXPOSURE;

ANTI-HIV AGENTS; CONGENITAL ABNORMALITIES; FEMALE; HEART DEFECTS, CONGENITAL; HIV INFECTIONS; HUMANS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84900418063     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001636     Document Type: Article

References (14)

1. Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, et al. (2002) Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J AIDS 29: 484-494.
2. Nesheim S, Harris LF, Lampe M, (2013) Elimination of perinatal HIV infection in the USA and other high-income countries: achievements and challenges. Curr Opin HIVAIDS 8: 447-456.
3. The United States President's Emergency Plan for AIDS Relief. PEPFAR Tenth Annual Report To Congress (2014). See URL http://www.pepfar.gov/documents/organization/223065.pdf.
4. World Health Organization (2013) Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach. Available: http://www.who.int/hiv/pub/guidelines/arv2013/download/en/index.html.
5. Sibiude J, Mandelbrot L, Blanche S, Le Chenadec J, Boullag-Bonnet N, et al. (2014) Association between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the ANRS CO1/CO11 French Perinatal Cohort Study. PLoS Med 11: e1001635.
6. Townsend CL, Byrne L, Cortina-Borja M, Thorne C, de Ruiter A, et al. (2014) Earlier initiation of ART and futher decline in mother-to-child HIV transmission rates, 2000-2011. AIDS 28: 1049-57.
7. Polifka JE, Friedman JM, (1999) Clinical teratology: identifying teratogenic risks in humans. Clin Genet 56: 409-420.
8. Antiretroviral Pregnancy Registry Steering Committee (2013). Antiretroviral Pregnancy Registry Steering Committee. Antiretroviral pregnancy registry international interim report for 1 Jan 1989-31 July 2013. Wilmington (North Carolina): Registry Coordinating Center. Available: http://www.APRegistry.com.
9. Gomez O, Martinez JM, Olivella A, Bennasar M, Crispi F, et al. (2014) Isolated ventricular septal defects in the era of advanced fetal echocardiography: Risk of chromosomal anomalies and spontaneous closure rate from diagnosis to age of 1 year. Ultrasound Obstet Gynecol 43: 65-71.
10. Brogly SB, Abzug MJ, Watts DH, Cunningham CK, Williams PL, et al. (2010) Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trial protocols 219 and 219C. Pediatr Infect Dis J 29: 721-727.
11. Watts DH, Huang S, Culnane M, Kaiser KA, Scheuerle A, et al. (2011) Birth defects among a cohort of infants born to HIV-infected women on antiretroviral medication. J Perinat Med 39: 163-170.
12. Boyd PA, Haeusler M, Barisic I, Loane M, Garne E, et al. (2011) Paper 1: The EUROCAT network - organization and processes. Birth Defects Res A Clin Mol Teratol 91 Suppl 1: S2-S15.
13. Ford N, Calmy A, Mofenson L, (2011) Safety of efavirnez in the first trimester of pregnancy: an updated systematic review and meta-analysis. AIDS 25: 2301-2304.
14. Mehta U, Clerk C, Allen E, Yore M, Sevene E, et al. (2012) Protocol for a drugs exposure pregnancy registry implementation in resource limited settings. BMC Pregnancy Childbirth 12: 89.